Cytoplasmic membrane-associated protein (CAP) isolated from Streptococcus pyogenes: as a new bacterial superantigen.
A protein isolated from the cytoplasmic membranes of Streptococcus pyogenes (cytoplasmic membrane-associated protein, CAP) stimulated human T cells in vitro to induce their mitogenic response. This CAP-induced T cell proliferation required the presence of nylon-adherent accessory cells (AC) of either autologous or allogeneic origin in the reaction mixtures. In addition, the reaction was inhibited by monoclonal antibodies (mAbs) against major histocompatibility complex (MHC) class II molecules, HLA-DR and -DQ, but not -DP. Human lymphoid cell lines positive for HLA-DR but not those lacking it were also effective as AC for the reaction. A binding test using fluorescein-labeled protein revealed that CAP bound to the adherent monocytes and HLA-DR+ but not to -DR- lymphoid cell lines. The proliferative response of T cells to CAP was, however, not inhibited by the addition of the lysosomotrophic agent NH4Cl to the reaction mixtures. These results suggest that the presentation of CAP by AC to human T cells is mediated through binding of the protein to the MHC class II molecules but without being processed in the AC. The proliferative response of T cells was also found to be inhibited by addition of anti-CD2, -CD3 or -T cell receptor (TcR) mAbs. A major population responding to CAP was CD3+4+8- T cells. CAP also appears to stimulate T cells bearing V beta 8 sequences much more selectively than T cells bearing other V beta s. These results indicate that this streptococcal membrane protein, CAP, may be a new protein belonging to a group of bacterial superantigens.
Sato
H
H
Department of Microbiology, Tohoku University School of Dentistry, Sendai, Miyagi, Japan.
Itoh
T
T
Rikiishi
H
H
Kumagai
K
K
D000938:Antigen-Presenting Cells / Q000276:immunology; D001426:Bacterial Proteins / Q000276:immunology* / Q000302:isolation & purification* / Q000378:metabolism; D002462:Cell Membrane / Q000276:immunology; D003593:Cytoplasm / Q000276:immunology; D000949:Histocompatibility Antigens Class II / Q000378:metabolism; D006801:Humans; D066298:In Vitro Techniques; D008213:Lymphocyte Activation; D008565:Membrane Proteins / Q000276:immunology / Q000302:isolation & purification / Q000378:metabolism; D010641:Phenotype; D011485:Protein Binding; D016693:Receptors, Antigen, T-Cell, alpha-beta; D013297:Streptococcus pyogenes / Q000276:immunology*; D018089:Superantigens / Q000302:isolation & purification* / Q000378:metabolism; D013601:T-Lymphocytes / Q000276:immunology
D001426:Bacterial Proteins; D000949:Histocompatibility Antigens Class II; D008565:Membrane Proteins; D016693:Receptors, Antigen, T-Cell, alpha-beta; D018089:Superantigens